US OptionsDetailed Quotes
TZOO241220C20000
- 0.92
- 0.000.00%
15min DelayClose Nov 26 16:00 ET
0.00High0.00Low
0.92Open0.92Pre Close0 Volume181 Open Interest20.00Strike Price0.00Turnover53.99%IV5.55%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.92Extrinsic Value100Contract SizeAmericanOptions Type0.5091Delta0.1469Gamma19.34Leverage Ratio-0.0244Theta0.0058Rho9.84Eff Leverage0.0201Vega
Travelzoo Stock Discussion
looks good eps beats estimates may be money double opportunity
Travelzoo presents a prominent swing trading opportunity which is due to recent earnings, positive news catalysts, and the proximity to its 52-week high. The company's financials indicate profitability with a strong cash flow and a healthy balance sheet, further reinforced by a positive sentiment towards its stock. It's evident from recent price targets being raised by analysts alongside strategic decisions like stock buyback programs to enhance shareholder value. Despite o...
• $Allstate (ALL.US)$: Raymond James Upgrades to Strong Buy from Outperform - PT $165 (from $145)
• $DigitalBridge Group (DBRG.US)$: JPMorgan Upgrades to Neutral from Underweight - PT $7
• $Garmin (GRMN.US)$: BofA Securities Upgrades to Buy from Neutral - PT $140 (from $165)
• $Guidewire Software (GWRE.US)$: JMP Securities Upgrades to Market Outperform from Market Perform - PT $110
• $MongoDB (MDB.US)$: UBS Upgrades to Buy from Neutral - PT $450 (from $345)...
Sometimes I like to go through the biggest losers of the day and pick out the diamonds in the rough I just had a bad day.
$Aarons Holdings Co Inc (AAN.US)$ diamond in the rough
$Baudax Bio (BXRX.US)$
$Esperion Therapeutics (ESPR.US)$
$Proteostasis Therapeutics (PTI.US)$
No comment yet